British Journal of Haematology · 2021 · 10 citations · 40 references
Life SciencesCell BiologyHematologyRegenerative MedicineStem Cell BiologyStem Cell TransplantationHematopoietic DevelopmentHematopoietic DifferentiationHematopoietic RecoveryHematopoietic Stem Cell BiologyHematopoietic Stem Cell TransplantationHematopoietic Stem CellsCell Lineage RestrictionHematopoietic Stem Cell ExpansionHematopoietic Stem Cell MaintenanceHematopoietic Stem Cell RegenerationHematopoietic Stem Cell RescueLong-term Hematopoietic Stem Cells
Historically, defining haematopoietic subsets, including self-renewal, differentiation and lineage restriction, has been elucidated by transplanting a small number of candidate cells with many supporting bone marrow (BM) cells. While this approach has been invaluable in characterising numerous distinct subsets in haematopoiesis, this approach is arguably flawed. The haematopoietic stem cell (HSC) has been proposed as the critical haematopoietic subset necessary for transplantation. However, due to the presence of supporting cells, the HSC has never demonstrated sufficiency. Utilising the homeobox B5 (Hoxb5)-reporter system, we found that neither long-term (LT) HSCs nor short-term (ST) HSCs alone were sufficient for long-term haematopoietic reconstitution. Critically, reconstitution can be rescued by transplanting combined LT- and ST-HSCs, without supporting cells; a fraction we term the 'Minimum Subset for Transplantation' (MST). The MST accounts for only 0·005% of nucleated cells within mouse BM, and this MST can be cultured, expanded and genetically modified while preserving its rapid haematopoietic engraftment potential. These results support the consideration of an MST approach for clinical translation, especially for gene therapy approaches that require HSC compartment modification.
40
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
Shannon L. Maude, Theodore W. Laetsch, Jochen Buechner et al. · New England Journal of Medicine · 2018 · 5.6K citations · Full text
Medicine, Hematology, Oncology +17
Long-Term Lymphohematopoietic Reconstitution by a Single CD34-Low/Negative Hematopoietic Stem Cell
Masatake Osawa, Ken‐ichi Hanada, Hirofumi Hamada et al. · Science · 1996 · 2.1K citations
Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia
Marina Cavazzana, Emmanuel Payen, Olivier Nègre et al. · Nature · 2010 · 1.3K citations
Transplantation Outcomes for Severe Combined Immunodeficiency, 2000–2009
Sung‐Yun Pai, Brent R. Logan, Linda M. Griffith et al. · New England Journal of Medicine · 2014 · 771 citations · Full text
Medicine, Hematology, Pediatrics +14